Tatiana Bobrova received her Master’s degree in Pharmaceutical Sciences (Innovative Drugs) from the University of Burgundy. She conducted her master’s thesis research at the I3 lab of Sorbonne University, focusing on the preclinical development of a 3rd generation Interleukin 2 in a mouse model for autoimmune and inflammatory diseases. Her bachelor’s scientific research delved into the antitumor activity of iron oxide Fe3O4 magnetic nanoparticles loaded with doxorubicin under the influence of an alternative magnetic field.
She has also been recognized as a winner in Russian scientific competitions, including the Federal Student Tournament of Three Sciences and the Student Biological Tournament (finalist).
Tatiana Bobrova is now doctoral researcher at Invectys, working on synergic therapy for solid tumours, by combining CAR-T cells with the properties of magnetic nanoparticles.
